SFORZA, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 1.459
EU - Europa 486
AS - Asia 254
AF - Africa 2
Totale 2.201
Nazione #
US - Stati Uniti d'America 1.453
PL - Polonia 148
CN - Cina 129
IT - Italia 114
SG - Singapore 75
UA - Ucraina 73
GB - Regno Unito 52
DE - Germania 45
TR - Turchia 38
FI - Finlandia 21
BE - Belgio 15
SE - Svezia 13
CA - Canada 6
ID - Indonesia 5
IR - Iran 3
TN - Tunisia 2
VN - Vietnam 2
CZ - Repubblica Ceca 1
FR - Francia 1
IN - India 1
JP - Giappone 1
LT - Lituania 1
NL - Olanda 1
RO - Romania 1
Totale 2.201
Città #
Fairfield 199
Ann Arbor 180
Warsaw 148
Woodbridge 142
Houston 122
Chandler 96
Ashburn 95
Jacksonville 95
Cambridge 76
Ferrara 72
Santa Clara 61
Seattle 61
Wilmington 61
Singapore 60
Beijing 43
Izmir 25
Nanjing 19
Princeton 19
San Diego 18
Milan 17
Brussels 15
Shanghai 15
Boardman 13
Los Angeles 11
Mountain View 8
Nanchang 8
Shenyang 8
Addison 6
Changsha 6
Hebei 6
London 6
Redwood City 6
Jakarta 5
Jiaxing 5
Bremen 4
Cagliari 4
Helsinki 4
New York 4
Ardabil 3
Jinan 3
Kunming 3
Modena 3
Munich 3
Tianjin 3
Toronto 3
Bologna 2
Dearborn 2
Dong Ket 2
Falkenstein 2
Falls Church 2
Guangzhou 2
Indiana 2
Leawood 2
Ottawa 2
Rome 2
San Mateo 2
Auburn Hills 1
Augusta 1
Brno 1
Camerino 1
Chengdu 1
Chiswick 1
Council Bluffs 1
Farmville 1
Forest City 1
Frankfurt am Main 1
Fuzhou 1
Handan 1
Jining 1
La Canada Flintridge 1
Lanzhou 1
Montréal 1
New Bedfont 1
Norwalk 1
Orange 1
Osimo 1
Prescot 1
Redmond 1
San Francisco 1
Taranto 1
Tokyo 1
Yellow Springs 1
Totale 1.812
Nome #
The HIV-Tat protein favors the activation of T lymphocytes. Implications for new therapeutic strategies against HIV and other viral infections 187
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 161
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 137
Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides 132
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: production, characterization and in vitro studies 131
Synthesis, characterization and antiproliferative activity of three platinum(II) complexes of L-​carnitine. The first structural determination of a platinum complex containing carnitine 130
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 121
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 117
Acetylcholine-like and Trimethylglycine-like PTA (1,3,5-Triaza-7-phosphaadamantane) Derivatives for the Development of Innovative Ru- and Pt-Based Therapeutic Agents 117
UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion 117
Platinum and ruthenium complexes of new long-tail derivatives of PTA (1,3,5-triaza-7-phosphaadamantane): Synthesis, characterization and antiproliferative activity on human tumoral cell lines 110
Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs 108
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors. 108
null 107
null 106
Unexpected One-Pot Synthesis of Highly Conjugated Pentacyclic Diquinoid Compounds 94
New PTA (1,3,5-triaza 7-phosphaadamantane) derivatives associating zwitterionic structure and coordinativa ability 90
Modified N,O-nucleosides: design, synthesis and evaluation of the antitumor activity 64
null 43
Synthesis and in vitro cytotoxicity of deoxyadenosine-​bile acid conjugates linked with 1,​2,​3-​triazole 33
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors 28
Totale 2.241
Categoria #
all - tutte 9.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.478


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020234 0 0 0 0 0 0 46 48 43 47 36 14
2020/2021337 33 26 12 34 13 32 16 42 20 58 40 11
2021/2022226 9 20 23 11 5 9 21 11 13 17 25 62
2022/2023217 23 6 13 35 29 26 17 23 27 1 11 6
2023/2024107 9 19 4 0 6 22 4 12 2 3 0 26
2024/2025182 5 9 45 21 47 55 0 0 0 0 0 0
Totale 2.241